QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 incannex-healthcare-board-authorizes-share-repurchase-program-for-up-to-20m

Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical compan...

 incannex-announces-it-has-received-patient-reported-outcomes-and-phase-2-efficacy-data-for-ihl-42x-in-obstructive-sleep-apnoea-with-895-of-participants-describing-a-meaningful-change-to-their-lives

Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage pharmaceutical company developing innovative combination therapies for...

 nano-cap-incannexs-sleep-apnea-candidate-shows-effectiveness-and-safety-in-mid-stage-trial

Incannex's IHL-42X showed significant efficacy in Phase 2 sleep apnea trial, with strong AHI reduction, improved sleep, and...

 incannex-reports-phase-2-results-for-ihl-42x-reducing-sleep-apnea-severity-by-up-to-83-with-strong-safety-profile

Statistically and clinically significant improvements across key clinical endpoints; IHL-42X reduced AHI by up to 83% from base...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION